108 related articles for article (PubMed ID: 27751764)
1. Evaluation of interleukin 12 and CD56+ lymphocyte cells in pediatric hematopoietic stem cell transplantation for early diagnosis of acute graft versus host disease.
Tootoonchian R; Pak F; Ardekani AM; Sehati N; Abedi-Valugerdi M; Kokhaei P
Transpl Immunol; 2016 Nov; 39():25-29. PubMed ID: 27751764
[TBL] [Abstract][Full Text] [Related]
2. Human interferon-alpha increases the cytotoxic effect of CD56(+) cord blood-derived cytokine-induced killer cells on human B-acute lymphoblastic leukemia cell lines.
Durrieu L; Gregoire-Gauthier J; Dieng MM; Fontaine F; le Deist F; Haddad E
Cytotherapy; 2012 Nov; 14(10):1245-57. PubMed ID: 22974386
[TBL] [Abstract][Full Text] [Related]
3. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Sairafi D; Stikvoort A; Gertow J; Mattsson J; Uhlin M
J Immunol Res; 2016; 2016():5601204. PubMed ID: 27965986
[No Abstract] [Full Text] [Related]
4. CD56
Kariminia A; Ivison S; Ng B; Rozmus J; Sung S; Varshney A; Aljurf M; Lachance S; Walker I; Toze C; Lipton J; Lee SJ; Szer J; Doocey R; Lewis I; Smith C; Chaudhri N; Levings MK; Broady R; Devins G; Szwajcer D; Foley R; Mostafavi S; Pavletic S; Wall DA; Couban S; Panzarella T; Schultz KR
Haematologica; 2017 Nov; 102(11):1936-1946. PubMed ID: 28935847
[TBL] [Abstract][Full Text] [Related]
5. Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.
Lugthart G; Melsen JE; Vervat C; van Ostaijen-Ten Dam MM; Corver WE; Roelen DL; van Bergen J; van Tol MJ; Lankester AC; Schilham MW
J Immunol; 2016 Jul; 197(1):78-84. PubMed ID: 27226093
[TBL] [Abstract][Full Text] [Related]
6. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
7. Expression of killer cell inhibitor receptors on immunocompetent cells with relation to graft-versus-host disease after hematopoietic stem cell transplantation.
Duan LN; Chen C; Huang SL; Fang JP; Wei J; Bao R; Li Y; Han HX; Li SN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):625-32. PubMed ID: 14706148
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
9. Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease.
Khandelwal P; Lane A; Chaturvedi V; Owsley E; Davies SM; Marmer D; Filipovich AH; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1215-22. PubMed ID: 25881755
[TBL] [Abstract][Full Text] [Related]
10. Unique effects of mycophenolate mofetil on cord blood T cells: implications for GVHD prophylaxis.
Derniame S; Lee F; Domogala A; Madrigal A; Saudemont A
Transplantation; 2014 Apr; 97(8):870-8. PubMed ID: 24670298
[TBL] [Abstract][Full Text] [Related]
11. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.
Zhao XY; Wang YT; Mo XD; Zhao XS; Wang YZ; Chang YJ; Huang XJ
J Transl Med; 2015 May; 13():145. PubMed ID: 25948100
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients.
Yabe M; Yabe H; Hattori K; Shimizu T; Matsumoto M; Morimoto T; Yasuda Y; Inoue H; Kato S; Nishimura T
Bone Marrow Transplant; 1999 Jul; 24(1):29-34. PubMed ID: 10435731
[TBL] [Abstract][Full Text] [Related]
16. Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections.
Huenecke S; Cappel C; Esser R; Pfirrmann V; Salzmann-Manrique E; Betz S; Keitl E; Banisharif-Dehkordi J; Bakhtiar S; Königs C; Jarisch A; Soerensen J; Ullrich E; Klingebiel T; Bader P; Bremm M
Front Immunol; 2017; 8():109. PubMed ID: 28239380
[TBL] [Abstract][Full Text] [Related]
17. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
Chang YJ; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
[TBL] [Abstract][Full Text] [Related]
18. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
[TBL] [Abstract][Full Text] [Related]
19. Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors.
Yan CH; Liu DH; Xu LP; Liu KY; Zhao T; Wang Y; Chen H; Chen YH; Han W; Huang XJ
Clin Transplant; 2012; 26(6):868-76. PubMed ID: 22432715
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells.
Ukena SN; Geffers R; Buchholz S; Stadler M; Franzke A
Transpl Immunol; 2012 Dec; 27(4):179-83. PubMed ID: 22889700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
